MorphoSys AG (MOR)
19.00
-0.34
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
18.98
-0.02
(-0.11%)
After-Hours: 20:00
MorphoSys Price to Book Value: 52.87 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 52.87 |
| May 16, 2024 | 53.81 |
| May 15, 2024 | 51.48 |
| May 14, 2024 | 51.17 |
| May 13, 2024 | 50.28 |
| May 10, 2024 | 50.09 |
| May 09, 2024 | 49.72 |
| May 08, 2024 | 49.97 |
| May 07, 2024 | 49.92 |
| May 06, 2024 | 50.03 |
| May 03, 2024 | 49.78 |
| May 02, 2024 | 49.72 |
| May 01, 2024 | 48.72 |
| April 30, 2024 | 48.44 |
| April 29, 2024 | 48.30 |
| April 26, 2024 | 50.20 |
| April 25, 2024 | 50.45 |
| April 24, 2024 | 50.22 |
| April 23, 2024 | 50.20 |
| April 22, 2024 | 49.97 |
| April 19, 2024 | 50.03 |
| April 18, 2024 | 50.22 |
| April 17, 2024 | 50.04 |
| April 16, 2024 | 49.79 |
| April 15, 2024 | 49.99 |
| Date | Value |
|---|---|
| April 12, 2024 | 50.10 |
| April 11, 2024 | 50.07 |
| April 10, 2024 | 49.99 |
| April 09, 2024 | 50.38 |
| April 08, 2024 | 50.35 |
| April 05, 2024 | 50.18 |
| April 04, 2024 | 50.15 |
| April 03, 2024 | 50.21 |
| April 02, 2024 | 50.10 |
| April 01, 2024 | 50.24 |
| March 28, 2024 | 50.32 |
| March 27, 2024 | 50.32 |
| March 26, 2024 | 50.43 |
| March 25, 2024 | 50.35 |
| March 22, 2024 | 50.43 |
| March 21, 2024 | 50.02 |
| March 20, 2024 | 50.02 |
| March 19, 2024 | 50.18 |
| March 18, 2024 | 50.21 |
| March 15, 2024 | 49.49 |
| March 14, 2024 | 49.77 |
| March 13, 2024 | 50.04 |
| March 12, 2024 | 50.40 |
| March 11, 2024 | 49.63 |
| March 08, 2024 | 49.68 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.79
Minimum
Dec 06 2021
53.81
Maximum
May 16 2024
11.34
Average
5.652
Median
Sep 29 2020
Price to Book Value Benchmarks
| Novartis AG | 5.275 |
| Immatics NV | 2.610 |
| Affimed NV | 1.251 |
| InflaRx NV | 0.9379 |
| BioNTech SE | 1.013 |
Price to Book Value Related Metrics
| PS Ratio | 10.11 |
| PEG Ratio | -0.7222 |
| Price | 19.00 |
| Earnings Yield | -7.91% |
| Market Cap | 2.866B |
| PEGY Ratio | -0.7222 |